Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
RXST | US
0.52
7.69%
Healthcare
Medical Devices
30/06/2024
08/04/2026
7.28
7.11
7.29
7.00
RxSight Inc. an ophthalmic medical device company engages in the research and development manufacture and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light delivery device an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision Inc. and changed its name to RxSight Inc. in February 2017. RxSight Inc. was incorporated in 1997 and is headquartered in Aliso Viejo California.
View LessStrength based on increasing price with high volume
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
High Short-term Volatility
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
67.4%1 month
62.7%3 months
64.5%6 months
64.2%-
108.70
7.21
0.04
0.04
-7.70
15.31
-
-38.31M
288.89M
288.89M
-
-23.89
-
67.60
-17.01
4.84
5.97
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
1.39
Range1M
1.91
Range3M
5.06
Rel. volume
1.40
Price X volume
7.92M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Perspective Therapeutics Inc. | CATX | Medical Devices | 4.37 | 294.66M | 0.00% | n/a | 0.00% |
| Cellpoint Inc | CLPT | Medical Devices | 9.17 | 253.05M | 1.10% | n/a | 42.94% |
| 908 Devices Inc | MASS | Medical Devices | 7.03 | 243.64M | 3.99% | n/a | 3.58% |
| Harvard Bioscience Inc | HBIO | Medical Instruments & Supplies | 5.55 | 242.04M | 2.78% | n/a | 61.64% |
| OraSure Technologies Inc | OSUR | Medical Instruments & Supplies | 3.08 | 229.67M | 0.65% | 11.53 | 2.96% |
| Utah Medical Products Inc | UTMD | Medical Instruments & Supplies | 64.53 | 224.38M | 1.67% | 15.31 | 0.22% |
| BRAINSWAY LTD | BWAY | Medical Devices | 13.23 | 220.65M | 7.91% | 503.00 | 10.16% |
| Outset Medical Inc | OM | Medical Devices | 4.2 | 218.78M | 2.44% | n/a | 294.91% |
| Electromed Inc | ELMD | Medical Devices | 24.4 | 205.08M | 2.61% | 39.79 | 0.20% |
| InfuSystem Holdings Inc | INFU | Medical Instruments & Supplies | 9.47 | 201.86M | 1.18% | 702.00 | 73.21% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| ACCO Brands Corporation | ACCO | Building Products & Equipment | 2.91 | 278.77M | 2.46% | n/a | 174.23% |
| Urban One Inc | UONEK | Broadcasting - Radio | 5.23 | 277.23M | n/a | 268.43% | |
| The RMR Group Inc | RMR | Real Estate Services | 16.12 | 269.60M | 1.96% | 16.64 | 14.14% |
| Comstock Holding Companies Inc | CHCI | Real Estate Services | 18.86 | 185.99M | 0.05% | 14.10 | 17.12% |
| CPI Card Group Inc | PMTS | Building Products & Equipment | 16.56 | 184.77M | 1.41% | 15.61 | -621.78% |
| RE/MAX Holdings Inc | RMAX | Real Estate Services | 5.81 | 182.53M | 1.22% | n/a | 114.28% |
| Douglas Elliman Inc. | DOUG | Real Estate Services | 1.69 | 155.20M | 5.63% | n/a | 62.82% |
| STHO | STHO | Real Estate Services | 8.09 | 107.76M | 1.38% | n/a | 59.21% |
| Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 34.71 | 99.68M | 5.16 | 19.82% | |
| Virco Mfg. Corporation | VIRC | Building Products & Equipment | 5.68 | 92.52M | -5.33% | 9.09 | 39.79% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -7.70 | 46.09 | Cheaper |
| Ent. to Revenue | 15.31 | 14.34 | Par |
| PE Ratio | - | 30.41 | - |
| Price to Book | 7.21 | 6.21 | Par |
| Dividend Yield | - | 1.78 | - |
| Std. Deviation (3M) | 64.50 | 64.12 | Par |
| Debt to Equity | 0.04 | -145.53 | Expensive |
| Debt to Assets | 0.04 | 0.35 | Cheaper |
| Market Cap | 288.89M | 9.70B | Emerging |